Pharm Tech Minutes 2021.06.23

Minutes

Welcome

• Participants
  • Jose Costa Teixeira
  • Stephane Spahni
  • Michael Tan
  • Juergen Brandstaetter
  • Marc Robberecht

• Review and Approve Agenda

Medication lists

• Sandbox Belgium
• A patient has a treatment plan. This could initiated by the patient, but more often it could be a plan from a Care Provider.
• There could be multiple plans from different care providers.
• The diagram is actually treatment centric.
• Agreement that there is a treatment, but difference is where to draw the line.
• In the NL the treatment line is part of the prescription and the prescription is similar with the supply request.
• the rules where to find the correct dosage will depend on the settings in the different countries.
• rules to the period will differ per country. A current medication summary in NL means the last 6 months. In Switzerland it is what the patient is using now. Point is that we would like to define the differences.
• Within FHIR it makes it easier to map to another format from another country.
• The IPS is just a collection of medication statements.
• We should not use the same name as IPS. Suggestion to use medication treatment view.
• Indication is mentioned on different levels. It also depends on the setting where to mention the indication.

• Action items:
  • generic guidelines
  • Mapping to different country settings. Belgium, Switzerland, Netherlands, France, Austria.

• Links:
  • http://build.fhir.org/ig/hl7-be/riziv-inami/artifacts.html
  • http://build.fhir.org/ig/hl7-be/riziv-inami/medicationrecord-fhir-resources.html